Clik here to view.
New Precision Medicine Approved for Specific Patients with Lung Cancer
Last week, the U.S. Food and Drug Administration (FDA) provided some good news for the lung cancer community during Lung Cancer Awareness Month when it approved both a new precision medicine,...
View ArticleClik here to view.
Two New Therapeutics Approved For Treating Multiple Myeloma
The flurry of decisions from the U.S. Food and Drug Administration (FDA) on investigational anticancer therapeutics continued last week when the agency approved two new agents for treating certain...
View ArticleClik here to view.
FDA Expands Use of Immunotherapeutic to Kidney Cancer
On Monday, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the immunotherapeutic agent nivolumab (Opdivo) for treating certain patients with advanced renal cell...
View ArticleClik here to view.
FDA Increases Treatment Options for Certain Patients With Lung Cancer
As lung cancer awareness month drew to a close, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for oncologists treating certain patients with lung cancer:...
View ArticleClik here to view.
Third New Treatment for Multiple Myeloma Approved in November
On Monday, the U.S. Food and Drug Administration (FDA) rounded out an exciting month for the multiple myeloma community when it approved a third new treatment for certain patients with the disease in...
View ArticleClik here to view.
FDA Approves New Targeted Therapeutic for Lung Cancer
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when alectinib (Alecensa) was approved for treating certain patients with advanced...
View ArticleClik here to view.
Advancing Lung Cancer Research
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S. Food and Drug Administration for treating patients with...
View ArticleClik here to view.
A Need to Increase Awareness of HPV Vaccines and Cervical Cancer Prevention
Cancer awareness months provide an opportunity to increase public knowledge of all aspects of a particular cancer, from prevention, to treatment, to issues surrounding survivorship. This month is...
View ArticleClik here to view.
Celebrating 75 Years of Publishing Cancer Research
The dawning of the new year marked the 75th anniversary of the publication of the first issue of Cancer Research, the flagship journal of the American Association for Cancer Research. To commemorate...
View ArticleClik here to view.
New FDA-approved Therapeutic Improves Survival for Patients With Liposarcoma
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most common types of soft tissue sarcoma, liposarcoma. The therapeutic, eribulin mesylate (Halaven),...
View ArticleClik here to view.
FDA Expands Use of Immunotherapeutic to Follicular Lymphoma
At the end of last week, the U.S. Food and Drug Administration (FDA) approved the immunotherapeutic obinutuzumab (Gazyva) for treating certain patients with follicular lymphoma, which is the...
View ArticleClik here to view.
FDA Expands Use of Targeted Therapeutic for Lung Cancer
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori) for treating certain patients with advanced non–small cell lung cancer (NSCLC)....
View ArticleClik here to view.
FDA Approves New Treatment for Certain Patients With Leukemia
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it approved venetoclax (Venclexta) for the treatment of certain...
View ArticleClik here to view.
FDA Approves Blood-based Colorectal Cancer Screening Test
Earlier this month, the U.S. Food and Drug Administration (FDA) approved a new colorectal cancer screening test, the ‘System, Colorectal Neoplasia, DNA Methylation and Hemoglobin Detection’ test....
View ArticleClik here to view.
FDA Expands Use of Antiangiogenic to Kidney Cancer
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the antiangiogenic therapeutic cabozantinib (Cabometyx) for treating certain patients with advanced...
View ArticleClik here to view.
FDA Expands Use of Molecularly Targeted Therapeutic for Lung Cancer
The U.S. Food and Drug Administration (FDA) recently approved the use of molecularly targeted therapeutic afatinib (Gilotrif) for treating patients with metastatic squamous non–small cell lung cancer...
View ArticleClik here to view.
FDA Increases Antiangiogenic Treatment Options for Kidney Cancer
Late last week, the U.S. Food and Drug Administration (FDA) added another antiangiogenic therapeutic to the armamentarium for oncologists treating certain patients with kidney cancer: lenvatinib...
View ArticleClik here to view.
Burning Issues in Skin Cancer Prevention
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin cancer, including 90 percent of cases of melanoma—the most deadly form of the...
View ArticleClik here to view.
Bladder Cancer and Hodgkin Lymphoma FDA Approvals Expand Immunotherapy’s Reach
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known as checkpoint inhibitors are an approved treatment option. On Tuesday, the...
View ArticleClik here to view.
Weighing Up the Cancer Problem
One of the most effective ways a person can lower his or her risk of developing cancer is by maintaining a healthy weight. This is because being overweight or obese increases the chance that a person...
View Article
